Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2015 Sep 4:5:13598.
doi: 10.1038/srep13598.

The nitric oxide synthase 3 G894T polymorphism associated with Alzheimer's disease risk: a meta-analysis

Shengyuan Liu  1   2 , Fangfang Zeng  3 , Changyi Wang  2 , Zhongwei Chen  2 , Bin Zhao  4 , Keshen Li  1
Affiliations
Meta-Analysis

The nitric oxide synthase 3 G894T polymorphism associated with Alzheimer's disease risk: a meta-analysis

Shengyuan Liu et al. Sci Rep. .

Abstract

The association between the G894T polymorphism (Glu298Asp) of nitric oxide synthase 3 (NOS3) and risk of Alzheimer's disease (AD) was explored by performing a meta-analysis of case-control studies. Bibliographical searches were conducted in the MEDLINE, EMBASE, and China National Knowledge Infrastructure (CNKI) databases without any language limitations. Two investigators independently assessed abstracts for relevant studies, and reviewed all eligible studies. We adopted regrouping in accordance with the most probably appropriate genetic model. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of this association. We performed a meta-analysis including 21 published articles with 23 case-control studies (5,670 cases and 5,046 controls). In the analyses, we found significant association between G894T polymorphism and AD risk under a complete overdominant model (GG + TT vs. GT) (OR = 1.18; 95%CI, 1.04-1.35; P = 0.010). When stratified by time of AD onset, we found the association between this polymorphism and AD susceptibility to be more substantial among late onset patients than among early onset patients (OR for late vs. early onset: 1.33 vs. 1.02, P interaction = 0.049). The meta-analysis showed that the polymorphism G894T of NOS3 was associated with risk of AD.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Flow chart of selection studies in our meta-analysis.
Figure 2
Figure 2. Forest plot of association between NOS3 G894T polymorphism (G/G+T/T vs. G/T) and AD risk.
Figure 3
Figure 3. Funnel plot of association between NOS3 G894T polymorphism (G/G+T/T vs. G/T) and the risk of AD risk.
See this image and copyright information in PMC

References

    1. Querfurth H. W. & LaFerla F. M. Alzheimer’s disease. N Engl J Med 362, 329–344 (2010). - PubMed
    1. Wimo A. & Prince M. Alzheimer’s disease International. World Alzheimer Report 2009-2011. Available from: http://www.alz.co.uk/research/world-report, accessed on 11/02/2015 (2011).
    1. Berchtold N. C. & Cotman C. W. Evolution in the conceptualization of dementia and Alzheimer’s disease: Greco-Roman period to the 1960s. Neurobiol Aging 19, 173–189 (1998). - PubMed
    1. Galbusera C. et al. Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients. Curr Alzheimer Res 1, 103–109 (2004). - PubMed
    1. Marsden P. A. et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 268, 17478–17488 (1993). - PubMed

Publication types